Skip to main content
VCbacked
Log inGet Started

Ocusphere Therapeutics Inc

Hayward, United States

Ocusphere Therapeutics Inc. is a biotech startup focused on gene therapy using non-viral vectors, targeting inherited retinal diseases.

$400K raised
Feb 2024
Pre-Seed
BiopharmaBiotechnologyGeneticsLife Science

Top Investors

Hanxing Huang

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ocusphere Therapeutics Inc

How much funding has Ocusphere Therapeutics Inc raised?
Ocusphere Therapeutics Inc has raised $400K in total funding. The most recent round was Pre-Seed. The last funding was announced in February 2024.
Who are Ocusphere Therapeutics Inc's investors?
Ocusphere Therapeutics Inc's investors include Hanxing Huang.
Where is Ocusphere Therapeutics Inc headquartered?
Ocusphere Therapeutics Inc is headquartered in Hayward, United States.
What does Ocusphere Therapeutics Inc do?
Ocusphere Therapeutics Inc. is a biotech startup focused on gene therapy using non-viral vectors, targeting inherited retinal diseases.
What stage is Ocusphere Therapeutics Inc at?
Ocusphere Therapeutics Inc is at the Pre-Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Ocusphere Therapeutics Inc — Funding & Investors." VCBacked, February 10, 2024, https://www.vcbacked.co/company/ocusphere-therapeutics-inc. Accessed July 2, 2026.
APA
VCBacked. (2024). Ocusphere Therapeutics Inc — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/ocusphere-therapeutics-inc
Wikipedia (cite web)
{{cite web |title=Ocusphere Therapeutics Inc — Funding & Investors |url=https://www.vcbacked.co/company/ocusphere-therapeutics-inc |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
Allterum Therapeutics
Houston$1.0M
Epsilogen
London$16.3M
Cairn Therapeutics
Tucson$3.0M
Living In Silico Inc.
Brampton$3K
KuriBio
Berkeley$150K
Systemic Bio
Houston$15.0M